Gene symbol | ERBB2 | Synonyms | CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19, NEU, NGL, TKR1, VSCN2, c-ERB-2, c-ERB2, p185(erbB2) | Type of gene | protein-coding |
Chromosome | 17 | Map location | 17q12 | dbXrefs | |
Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
Description | erb-b2 receptor tyrosine kinase 2 |
GTO ID | GTC1530 |
Trial ID | NCT02442297 |
Disease | Brain Cancer |
Altered gene | HER2 |
Therapeutic/Target gene | Target gene |
Therapy | CAR-T cell |
Treatment | HER2 CAR-T cells |
Phase | Phase1 |
Recruitment status | Recruiting |
Title | T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors |
Year | 2015 |
Country | United States |
Company sponsor | Baylor College of Medicine |
Other ID(s) | H-31973-iCAR |
Cohort1: Dosing Schedule 1 | |||||||
|
|||||||
Cohort2: Dosing Schedule 2 | |||||||
|
|||||||
Cohort3: Dosing Schedule 3 | |||||||
|